China SXT Pharmaceuticals Statistics
Total Valuation
SXTC has a market cap or net worth of $22.04 million. The enterprise value is $14.76 million.
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
SXTC has 16.03 million shares outstanding. The number of shares has increased by 378.48% in one year.
| Current Share Class | 16.03M |
| Shares Outstanding | 16.03M |
| Shares Change (YoY) | +378.48% |
| Shares Change (QoQ) | +161.99% |
| Owned by Insiders (%) | 0.00% |
| Owned by Institutions (%) | 0.03% |
| Float | 16.03M |
Valuation Ratios
The trailing PE ratio is 0.07.
| PE Ratio | 0.07 |
| Forward PE | n/a |
| PS Ratio | 0.22 |
| Forward PS | n/a |
| PB Ratio | 0.05 |
| P/TBV Ratio | 1.56 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | 2.55 |
| EV / Sales | 8.12 |
| EV / EBITDA | 2.17 |
| EV / EBIT | 2.23 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.40, with a Debt / Equity ratio of 0.66.
| Current Ratio | 1.40 |
| Quick Ratio | 1.28 |
| Debt / Equity | 0.66 |
| Debt / EBITDA | 1.44 |
| Debt / FCF | n/a |
| Interest Coverage | 16.57 |
Financial Efficiency
Return on equity (ROE) is 57.63% and return on invested capital (ROIC) is 24.65%.
| Return on Equity (ROE) | 57.63% |
| Return on Assets (ROA) | 18.15% |
| Return on Invested Capital (ROIC) | 24.65% |
| Return on Capital Employed (ROCE) | 43.16% |
| Revenue Per Employee | $24,245 |
| Profits Per Employee | $77,267 |
| Employee Count | 75 |
| Asset Turnover | 0.08 |
| Inventory Turnover | 1.31 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -83.25% in the last 52 weeks. The beta is 1.25, so SXTC's price volatility has been higher than the market average.
| Beta (5Y) | 1.25 |
| 52-Week Price Change | -83.25% |
| 50-Day Moving Average | 2.09 |
| 200-Day Moving Average | 3.71 |
| Relative Strength Index (RSI) | 42.44 |
| Average Volume (20 Days) | 2,338,990 |
Short Selling Information
| Short Interest | 93,244 |
| Short Previous Month | 208,986 |
| Short % of Shares Out | 0.58% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.01 |
Income Statement
In the last 12 months, SXTC had revenue of $1.82 million and earned $5.80 million in profits. Earnings per share was $20.77.
| Revenue | 1.82M |
| Gross Profit | 400,384 |
| Operating Income | 6.62M |
| Pretax Income | -14.14M |
| Net Income | 5.80M |
| EBITDA | 6.79M |
| EBIT | 6.62M |
| Earnings Per Share (EPS) | $20.77 |
Full Income StatementBalance Sheet
The company has $18.51 million in cash and $9.87 million in debt, giving a net cash position of $8.64 million or $0.54 per share.
| Cash & Cash Equivalents | 18.51M |
| Total Debt | 9.87M |
| Net Cash | 8.64M |
| Net Cash Per Share | $0.54 |
| Equity (Book Value) | 15.03M |
| Book Value Per Share | 30.79 |
| Working Capital | 6.32M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$2.71 million and capital expenditures -$7,063, giving a free cash flow of -$2.71 million.
| Operating Cash Flow | -2.71M |
| Capital Expenditures | -7,063 |
| Free Cash Flow | -2.71M |
| FCF Per Share | -$0.17 |
Full Cash Flow StatementMargins
Gross margin is 22.02%, with operating and profit margins of 363.97% and 318.69%.
| Gross Margin | 22.02% |
| Operating Margin | 363.97% |
| Pretax Margin | 318.69% |
| Profit Margin | 318.69% |
| EBITDA Margin | 373.27% |
| EBIT Margin | 363.97% |
| FCF Margin | n/a |